Literature DB >> 8730341

Clinical spectrum, investigations and treatment of Budd-Chiari syndrome.

A E Mahmoud1, A Mendoza, A N Meshikhes, S Olliff, R West, J Neuberger, J Buckels, J Wilde, E Elias.   

Abstract

The clinical presentation, investigations, therapeutic modalities, prognosis and outcome of 44 patients with Budd-Chiari syndrome (BCS) were reviewed. There were 27 women and 17 men. Median age at presentation was 37 years (range 14-60). Possible aetiological factors were identified in 31 patients (70%). Myeloproliferative disorders were the commonest aetiology. Abdominal pain and swelling were the commonest presenting symptoms. Sixteen patients underwent a shunt operation (14 mesocaval, 2 mesoatrial). Ten patients had liver transplantation. Eleven patients had angioplasty/stent as their only treatment, and seven were treated medically or died before any treatment was instituted. Radiological intervention was comparable to mesocaval shunt in relieving patients' symptoms and in achieving good long-term results. Medical treatment and liver transplantation both yielded poor results. Radiological intervention in the form of balloon angioplasty or stent placement gives good results in a subgroup of BCS patients, and should be tried first to relieve the hepatic outflow obstruction. Mesocaval shunts provide good results in selected cases. Underlying haematological causes should be intensively investigated and promptly treated.

Entities:  

Mesh:

Year:  1996        PMID: 8730341     DOI: 10.1093/oxfordjournals.qjmed.a030135

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  17 in total

1.  Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.

Authors:  C E Eapen; D Velissaris; M Heydtmann; B Gunson; S Olliff; E Elias
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

2.  Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication.

Authors:  Nevin Oruc; Yaman Tokat; Refik Killi; Murat Tombuloglu; Tankut Ilter
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

3.  Aetiological factors of Budd-Chiari syndrome in Algeria.

Authors:  Nawel Afredj; Nawal Guessab; Abdelbasset Nani; Sid Ahmed Faraoun; Ibtissem Ouled Cheikh; Rafik Kerbouche; Djouhar Hannoun; Zine Charef Amir; Hayet Ait Kaci; Kamel Bentabak; Aurélie Plessier; Dominique-Charles Valla; Valerie Cazals-Hatem; Marie-Hélène Denninger; Tadjeddine Boucekkine; Nabil Debzi
Journal:  World J Hepatol       Date:  2015-04-28

4.  MDCT venography in the evaluation of inferior vena cava in Budd-Chiari syndrome: a road less travelled.

Authors:  Hemant Deshmukh; Krantikumar Rathod
Journal:  Indian J Gastroenterol       Date:  2009 Jan-Feb

5.  Chronic Budd-Chiari syndrome.

Authors:  Bhupinder Singh; Budnur C Srinivas
Journal:  CMAJ       Date:  2018-06-04       Impact factor: 8.262

6.  Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.

Authors:  A E Mahmoud; E Elias; N Beauchamp; J T Wilde
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

7.  Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting.

Authors:  N C Fisher; I McCafferty; M Dolapci; M Wali; J A Buckels; S P Olliff; E Elias
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

8.  Budd-Chiari syndrome: hepatic venous web outflow obstruction treated by percutaneous placement of hepatic vein stent.

Authors:  Alireza Bozorgmanesh; D Arul Selvam; James G Caridi
Journal:  Semin Intervent Radiol       Date:  2007-03       Impact factor: 1.513

Review 9.  Hepatic venous outflow obstruction: three similar syndromes.

Authors:  Ulas-Darda Bayraktar; Soley Seren; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

10.  Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome.

Authors:  Chun-Qing Zhang; Li-Na Fu; Lin Xu; Guo-Quan Zhang; Tao Jia; Ji-Yong Liu; Cheng-Yong Qin; Ju-Ren Zhu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.